JPWO2022250108A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022250108A5
JPWO2022250108A5 JP2023524226A JP2023524226A JPWO2022250108A5 JP WO2022250108 A5 JPWO2022250108 A5 JP WO2022250108A5 JP 2023524226 A JP2023524226 A JP 2023524226A JP 2023524226 A JP2023524226 A JP 2023524226A JP WO2022250108 A5 JPWO2022250108 A5 JP WO2022250108A5
Authority
JP
Japan
Prior art keywords
alkoxy
alkyl
same
halogen atoms
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023524226A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022250108A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/021531 external-priority patent/WO2022250108A1/ja
Publication of JPWO2022250108A1 publication Critical patent/JPWO2022250108A1/ja
Publication of JPWO2022250108A5 publication Critical patent/JPWO2022250108A5/ja
Pending legal-status Critical Current

Links

JP2023524226A 2021-05-26 2022-05-26 Pending JPWO2022250108A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021088034 2021-05-26
PCT/JP2022/021531 WO2022250108A1 (ja) 2021-05-26 2022-05-26 フェニルウレア誘導体

Publications (2)

Publication Number Publication Date
JPWO2022250108A1 JPWO2022250108A1 (cg-RX-API-DMAC7.html) 2022-12-01
JPWO2022250108A5 true JPWO2022250108A5 (cg-RX-API-DMAC7.html) 2025-06-02

Family

ID=84228903

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023524226A Pending JPWO2022250108A1 (cg-RX-API-DMAC7.html) 2021-05-26 2022-05-26

Country Status (11)

Country Link
US (1) US20240308960A1 (cg-RX-API-DMAC7.html)
EP (1) EP4353309A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2022250108A1 (cg-RX-API-DMAC7.html)
CN (1) CN117561238A (cg-RX-API-DMAC7.html)
AU (1) AU2022282786A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023024311A2 (cg-RX-API-DMAC7.html)
CA (1) CA3219888A1 (cg-RX-API-DMAC7.html)
IL (1) IL308659A (cg-RX-API-DMAC7.html)
MX (1) MX2023013975A (cg-RX-API-DMAC7.html)
TW (1) TW202313598A (cg-RX-API-DMAC7.html)
WO (1) WO2022250108A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11760747B2 (en) 2020-12-21 2023-09-19 Alkermes, Inc. Substituted piperidino compounds and related methods of treatment
US12006330B2 (en) 2020-12-21 2024-06-11 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment
JP7833486B2 (ja) 2021-05-26 2026-03-19 アルカーメス,インコーポレイテッド 置換されるカルバメート大環状化合物および関連のある治療方法
CA3248959A1 (en) * 2022-04-22 2025-02-03 Sumitomo Pharma Co., Ltd. BICYCLOAMINE CARBOXAMIDE DERIVATIVE
WO2025010311A1 (en) * 2023-07-05 2025-01-09 Vertex Pharmaceuticals Incorporated Urea-containing agonists of orexin receptor type 2
WO2025010314A1 (en) * 2023-07-05 2025-01-09 Vertex Pharmaceuticals Incorporated Urea-containing agonists of orexin receptor type 2
CN122374291A (zh) 2023-12-12 2026-07-10 爱杜西亚药品有限公司 作为食欲素受体调节剂的芳基砜及砜酮衍生物
WO2025132542A1 (en) 2023-12-19 2025-06-26 Idorsia Pharmaceuticals Ltd Macrocyclic orexin agonists

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1044282A1 (zh) * 1998-12-18 2002-10-18 Bristol-Myers Squibb Pharma Company 作为趋化因子受体活性调节剂的n-脲基烷基-哌啶化合物
US6331545B1 (en) * 1998-12-18 2001-12-18 Soo S. Ko Heterocycyclic piperidines as modulators of chemokine receptor activity
EP1330451B1 (en) * 2000-10-27 2008-01-23 Ortho-McNeil Pharmaceutical, Inc. Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators
JP4417108B2 (ja) * 2001-10-15 2010-02-17 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 新規な置換された4−フェニル−4−[1h−イミダゾール−2−イル]−ピペリジン誘導体および選択的非ペプチドデルタオピオイドアゴニストとしてのそれらの使用
AR041992A1 (es) * 2002-11-06 2005-06-08 Smithkline Beecham Corp Compuesto de piridinil benzoheterociclico, composicion farmaceutica que lo comprende y su uso para prepararla
WO2006007864A1 (en) * 2004-07-17 2006-01-26 Max Planck Geselllschaft Zur Förderung Der Wissenschaft Treating neurodegenerative conditions
US20090118200A1 (en) * 2005-05-23 2009-05-07 Bergman Jeffrey M Proline bis-amide orexin receptor antagonists
JP2009506061A (ja) * 2005-08-26 2009-02-12 メルク エンド カムパニー インコーポレーテッド ジアザスピロデカンオレキシン受容体拮抗薬
AR062841A1 (es) * 2006-09-15 2008-12-10 Schering Corp Tratamiento del dolor, diabetes, y trastornos del metabolismo de los lipidos
WO2008098859A1 (en) * 2007-02-15 2008-08-21 F. Hoffmann-La Roche Ag Hcv polymerase inhibitors
GB0813740D0 (en) * 2008-07-28 2008-09-03 Angeletti P Ist Richerche Biologica Therapeutic compounds
JP2010155827A (ja) * 2008-12-04 2010-07-15 Takeda Chem Ind Ltd スピロ環化合物
JP6346862B2 (ja) * 2012-02-07 2018-06-20 エオラス セラピューティクス, インコーポレイテッド オレキシンレセプターアンタゴニストとしての置換プロリン/ピペリジン
SG11201806429PA (en) 2016-02-04 2018-08-30 Takeda Pharmaceuticals Co Substituted piperidine compound and use thereof
US12048703B2 (en) * 2018-04-13 2024-07-30 University Of North Dakota Use of small molecule FAK activators to promote mucosal healing
WO2022093780A1 (en) * 2020-10-26 2022-05-05 University Of North Dakota Use of small molecule fak activators to promote mucosal healing

Similar Documents

Publication Publication Date Title
JP2019077713A5 (cg-RX-API-DMAC7.html)
CN103842332B (zh) 环丙胺化合物
JP2011517443A5 (cg-RX-API-DMAC7.html)
JP5215666B2 (ja) Bay43−9006トシレートの熱力学的に安定な形態
CO6531470A2 (es) Derivados benzamida sustituidos
EP2074113A1 (en) Indazolyl derivatives useful as potassium channel modulating agents
ECSP12012098A (es) Derivados de arilmetoxi isoindolina y composiciones que los comprenden y métodos para utilizar los mismos
JP2014528485A5 (cg-RX-API-DMAC7.html)
JP2010522721A (ja) プリニル誘導体及びカリウムチャネルモジュレーターとしてのそれらの使用
RU2009147708A (ru) Производные оксадиазола и их применение в качестве потенцирующих средств метаботропных глутаматных рецепторов-842
JP2017528502A5 (cg-RX-API-DMAC7.html)
JP2010520217A (ja) ヒスタミンh3受容体のモジュレーターとしてのテトラヒドロイソキノリン化合物
WO2022250108A1 (ja) フェニルウレア誘導体
WO2001060803A1 (en) Fused imidazolium derivatives
JP2020500869A5 (cg-RX-API-DMAC7.html)
JP2007500168A5 (cg-RX-API-DMAC7.html)
RU2006105782A (ru) Производные 1-сульфонилиндола, их получение и их применение в качестве лигандов 5-нт-6
JP7071959B2 (ja) スルホニルピリジルtrp阻害剤
RU2019120431A (ru) Производные триазинтриона и их использование в качестве модуляторов нейротрофиновых рецепторов и рецепторов тирозинкиназ
JP2009515934A (ja) 新規なキナゾリン誘導体及びこれらの医学的使用
JP6542236B2 (ja) 有機化合物
RU2023134503A (ru) Производное фенилмочевины
JP2011509296A5 (cg-RX-API-DMAC7.html)
JP2011506391A (ja) カリウムチャネル活性化因子として有用な、新規の2−エチル−メチル−アミノ−3−アミド−6−アミノ−ピリジン誘導体
JP2022183120A5 (cg-RX-API-DMAC7.html)